Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.

CONCLUSIONS: Transgelin-2 was expressed significantly higher in breast cancer cells and correlated with some clinicopathological factors. High transgelin-2 expression might predict poor prognosis for ER-negative patients.
PMID: 31144206 [PubMed - as supplied by publisher]

Source: Breast Cancer - May 28, 2019 Category: Cancer & Oncology Authors: Hao R, Liu Y, Du Q, Liu L, Chen S, You H, Dong Y Tags: Breast Cancer Source Type: research